The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis

Lim, Chong Seng Edwin, Sengupta, Raj and Gaffney, Karl ORCID: (2018) The clinical utility of human leucocyte antigen B27 in axial spondyloarthritis. Rheumatology, 57 (6). pp. 959-968. ISSN 1462-0324

Full text not available from this repository. (Request a copy)


The association between HLA-B27 and AS was first established in the early 1970s. Since then, our understanding of this disease has changed, such that we now recognize AS to be the extreme of the clinical phenotype within a disease spectrum known as axial SpA (axSpA). Recent advances in therapeutic options have driven the need for earlier diagnosis and many screening strategies have been proposed to facilitate this. In parallel, our understanding of axSpA genetics, and especially the contribution of HLA-B27, has expanded. In this article we will present and discuss the evidence supporting the use of HLA-B27 in clinical practice. We will briefly summarize the evolution of the concept of axSpA, the prevalence of HLA-B27 and axSpA and the potential role of HLA-B27 in the aetiopathogenesis of axSpA and focus on the utility of HLA-B27 in everyday clinical practice.

Item Type: Article
Uncontrolled Keywords: therapeutic use,early diagnosis,genetic markers,methods,methods,genetics,humans,phenotype,diagnosis
Faculty \ School:
Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: LivePure Connector
Date Deposited: 26 Aug 2020 00:01
Last Modified: 22 Oct 2022 06:39
DOI: 10.1093/rheumatology/kex345

Actions (login required)

View Item View Item